340 related articles for article (PubMed ID: 25744542)
21. Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition.
Dao KK; Teigen K; Kopperud R; Hodneland E; Schwede F; Christensen AE; Martinez A; Døskeland SO
J Biol Chem; 2006 Jul; 281(30):21500-21511. PubMed ID: 16728394
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of small molecules as potent and specific EPAC2 antagonists.
Chen H; Tsalkova T; Chepurny OG; Mei FC; Holz GG; Cheng X; Zhou J
J Med Chem; 2013 Feb; 56(3):952-62. PubMed ID: 23286832
[TBL] [Abstract][Full Text] [Related]
23. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.
Roscioni SS; Kistemaker LE; Menzen MH; Elzinga CR; Gosens R; Halayko AJ; Meurs H; Schmidt M
Respir Res; 2009 Sep; 10(1):88. PubMed ID: 19788733
[TBL] [Abstract][Full Text] [Related]
24. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration.
Yokoyama U; Minamisawa S; Quan H; Akaike T; Jin M; Otsu K; Ulucan C; Wang X; Baljinnyam E; Takaoka M; Sata M; Ishikawa Y
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1547-55. PubMed ID: 18689492
[TBL] [Abstract][Full Text] [Related]
25. Identification of A Novel Class of Benzofuran Oxoacetic Acid-Derived Ligands that Selectively Activate Cellular EPAC1.
Beck EM; Parnell E; Cowley A; Porter A; Gillespie J; Robinson J; Robinson L; Pannifer AD; Hamon V; Jones P; Morrison A; McElroy S; Timmerman M; Rutjes H; Mahajan P; Wiejak J; Luchowska-Stańska U; Morgan D; Barker G; Rehmann H; Yarwood SJ
Cells; 2019 Nov; 8(11):. PubMed ID: 31726720
[TBL] [Abstract][Full Text] [Related]
26. Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac.
Courilleau D; Bisserier M; Jullian JC; Lucas A; Bouyssou P; Fischmeister R; Blondeau JP; Lezoualc'h F
J Biol Chem; 2012 Dec; 287(53):44192-202. PubMed ID: 23139415
[TBL] [Abstract][Full Text] [Related]
27. The role of exchange protein directly activated by cyclic AMP 2-mediated calreticulin expression in the decidualization of human endometrial stromal cells.
Kusama K; Yoshie M; Tamura K; Nakayama T; Nishi H; Isaka K; Tachikawa E
Endocrinology; 2014 Jan; 155(1):240-8. PubMed ID: 24169561
[TBL] [Abstract][Full Text] [Related]
28. Epac: new emerging cAMP-binding protein.
Lee K
BMB Rep; 2021 Mar; 54(3):149-156. PubMed ID: 33298248
[TBL] [Abstract][Full Text] [Related]
29. Structure-guided design of selective Epac1 and Epac2 agonists.
Schwede F; Bertinetti D; Langerijs CN; Hadders MA; Wienk H; Ellenbroek JH; de Koning EJ; Bos JL; Herberg FW; Genieser HG; Janssen RA; Rehmann H
PLoS Biol; 2015 Jan; 13(1):e1002038. PubMed ID: 25603503
[TBL] [Abstract][Full Text] [Related]
30. Deficiency of exchange protein directly activated by cAMP (EPAC)-1 in mice augments glucose intolerance, inflammation, and gut dysbiosis associated with Western diet.
Virwani PD; Cai L; Yeung PKK; Qian G; Chen Y; Zhou L; Wong JWH; Wang Y; Ho JWK; Lau KK; Qian PY; Chung SK
Microbiome; 2022 Nov; 10(1):187. PubMed ID: 36329549
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs).
Liu Z; Zhu Y; Chen H; Wang P; Mei FC; Ye N; Cheng X; Zhou J
Bioorg Med Chem Lett; 2017 Dec; 27(23):5163-5166. PubMed ID: 29100797
[TBL] [Abstract][Full Text] [Related]
32. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
[TBL] [Abstract][Full Text] [Related]
33. A peek into Epac physiology in the kidney.
Tomilin VN; Pochynyuk O
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1094-F1097. PubMed ID: 31509013
[TBL] [Abstract][Full Text] [Related]
34. The cAMP sensors, EPAC1 and EPAC2, display distinct subcellular distributions despite sharing a common nuclear pore localisation signal.
Parnell E; Smith BO; Yarwood SJ
Cell Signal; 2015 May; 27(5):989-96. PubMed ID: 25683912
[TBL] [Abstract][Full Text] [Related]
35. Epac: a new cAMP target and new avenues in cAMP research.
Bos JL
Nat Rev Mol Cell Biol; 2003 Sep; 4(9):733-8. PubMed ID: 14506476
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides.
Rehmann H
Methods Enzymol; 2006; 407():159-73. PubMed ID: 16757322
[TBL] [Abstract][Full Text] [Related]
37. A Membrane Permeable Prodrug of S223 for Selective Epac2 Activation in Living Cells.
Xu Y; Schwede F; Wienk H; Tengholm A; Rehmann H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817822
[TBL] [Abstract][Full Text] [Related]
38. Direct activation of Epac by sulfonylurea is isoform selective.
Herbst KJ; Coltharp C; Amzel LM; Zhang J
Chem Biol; 2011 Feb; 18(2):243-51. PubMed ID: 21338921
[TBL] [Abstract][Full Text] [Related]
39. Epac proteins: multi-purpose cAMP targets.
Bos JL
Trends Biochem Sci; 2006 Dec; 31(12):680-6. PubMed ID: 17084085
[TBL] [Abstract][Full Text] [Related]
40. PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans.
Chepurny OG; Kelley GG; Dzhura I; Leech CA; Roe MW; Dzhura E; Li X; Schwede F; Genieser HG; Holz GG
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E622-33. PubMed ID: 20009023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
